Integration of 3-dimensional scar models from SPECT to guide ventricular tachycardia ablation

Journal of Nuclear Medicine

Volumn 53, Issue 6, 2012, Pages 894-901

  Tian, Jing ^a   Smith, Mark F ^a   Ahmad, Ghada ^a   Dilsizian, Vasken ^a   Jimenez, Alejandro ^a   Dickfeld, Timm ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BALTIMORE VA MEDICAL CENTER   (United States)

Author keywords

3D image integration; Electrophysiology; SPECT; Tachycardia; Ventricular tachycardia ablation

Indexed keywords

THALLIUM 201;

ABLATION THERAPY; AGED; ANALYTICAL ERROR; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ELECTRIC POTENTIAL; GOLD STANDARD; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE; HEART MUSCLE; HEART VENTRICLE TACHYCARDIA; HUMAN; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCAR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THREE DIMENSIONAL IMAGING;

AGED; BODY SURFACE POTENTIAL MAPPING; CATHETER ABLATION; HUMANS; IMAGING, THREE-DIMENSIONAL; MALE; MIDDLE AGED; TACHYCARDIA, VENTRICULAR; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84861848601     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.111.094904     Document Type: Article

References (18)

1. Marchlinski FE, Callans DJ, Gottlieb CD, Zado E. Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation. 2000;101:1288-1296. (Pubitemid 30158617)
2. Stevenson WG, Wilber DJ, Natale A, et al. Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial. Circulation. 2008;118:2773-2782.
3. Oza S, Wilber DJ. Substrate-based endocardial ablation of postinfarction ventricular tachycardia. Heart Rhythm. 2006;3:607-609.
4. Verma A, Marrouche NF, Schweikert RA, et al. Relationship between successful ablation sites and the scar border zone defined by substrate mapping for ventricular tachycardia post-myocardial infarction. J Cardiovasc Electrophysiol. 2005;16:465-471. (Pubitemid 40632476)
5. Aliot EM, Stevenson WG, Almendral-Garrote JM, et al. EHRA/HRS expert consensus on catheter ablation of ventricular arrhythmias: developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA). Heart Rhythm. 2009;6:886-933.
6. Tian J, Smith MF, Chinnadurai P, et al. Clinical application of PET/CT fusion imaging for three-dimensional myocardial scar and left ventricular anatomy during ventricular tachycardia ablation. J Cardiovasc Electrophysiol. 2008;20:597-604.
7. Dickfeld T, Lei P, Dilsizian V, et al. Integration of three-dimensional scar maps for ventricular tachycardia ablation using positron emission tomography/computed tomography (PET/CT). J Am Coll Cardiol Imaging. 2008;1:73-82. (Pubitemid 351445384)
8. Roes SD, Kaandorp TA, Marsan NA, et al. Agreement and disagreement between contrast-enhanced magnetic resonance imaging and nuclear imaging for assessment of myocardial viability. Eur J Nucl Med Mol Imaging. 2009;36:594-601.
9. Slart RH, Bax JJ, van Veldhuisen DJ, et al. Imaging techniques in nuclear cardiology for the assessment of myocardial viability. Int J Cardiovasc Imaging. 2006;22:63-80. (Pubitemid 43372355)
10. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;105:539-542. (Pubitemid 34262671)
11. Faris OP, Shein M. Food and Drug Administration perspective: magnetic resonance imaging of pacemaker and implantable cardioverter-defibrillator patients. Circulation. 2006;114:1232-1233. (Pubitemid 44402047)
12. Perazella MA. Current status of gadolinium toxicity in patients with kidney disease. Clin J Am Soc Nephrol. 2009;4:461-469.
13. Tian J, Jeudy J, Smith MF, et al. Three dimensional contrast enhanced multi-detector CT for anatomic, dynamic and perfusion characterization of abnormal myocardium to guide VT ablations. Circ Arrhythm Electrophysiol. 2010;3:496-504.
14. Maddahi J, Schelbert H, Brunken R, Di CM. Role of thallium-201 and PET imaging in evaluation of myocardial viability and management of patients with coronary artery disease and left ventricular dysfunction. J Nucl Med. 1994;35:707-715. (Pubitemid 24114575)
15. Czernin J, Porenta G, Brunken R, et al. Regional blood flow, oxidative metabolism, and glucose utilization in patients with recent myocardial infarction. Circulation. 1993;88:884-895. (Pubitemid 23264003)
16. Yoshida K, Gould KL. Quantitative relation of myocardial infarct size and myocardial viability by positron emission tomography to left ventricular ejection fraction and 3-year mortality with and without revascularization. J Am Coll Cardiol. 1993;22:984-997. (Pubitemid 23285746)
17. Dickfeld T, Tian J, Ahmad G, et al. MRI-guided ventricular tachycardia ablation: integration of late gadolinium-enhanced 3D scar in patients with implantable cardioverter-defibrillators. Circ Arrhythm Electrophysiol. 2011;4:172-184.
18. Wijnmaalen AP, van der Geest RJ, van Huls van Taxis CFB, et al. Head-to-head comparison of contrast-enhanced magnetic resonance imaging and electroanatomical voltage mapping to assess post-infarct scar characteristics in patients with ventricular tachycardias: real-time image integration and reversed registration. Eur Heart J. 2011;32:104-114.